Liu Hau, Bravata Dena M, Olkin Ingram, Friedlander Anne, Liu Vincent, Roberts Brian, Bendavid Eran, Saynina Olga, Salpeter Shelley R, Garber Alan M, Hoffman Andrew R
Santa Clara Valley Medical Center, San Jose, California 95128, USA.
Ann Intern Med. 2008 May 20;148(10):747-58. doi: 10.7326/0003-4819-148-10-200805200-00215. Epub 2008 Mar 17.
Human growth hormone is reportedly used to enhance athletic performance, although its safety and efficacy for this purpose are poorly understood.
To evaluate evidence about the effects of growth hormone on athletic performance in physically fit, young individuals.
MEDLINE, EMBASE, SPORTDiscus, and Cochrane Collaboration databases were searched for English-language studies published between January 1966 and October 2007.
Randomized, controlled trials that compared growth hormone treatment with no growth hormone treatment in community-dwelling healthy participants between 13 and 45 years of age.
2 authors independently reviewed articles and abstracted data.
44 articles describing 27 study samples met inclusion criteria; 303 participants received growth hormone, representing 13.3 person-years of treatment. Participants were young (mean age, 27 years [SD, 3]), lean (mean body mass index, 24 kg/m2 [SD, 2]), and physically fit (mean maximum oxygen uptake, 51 mL/kg of body weight per minute [SD, 8]). Growth hormone dosage (mean, 36 microg/kg per day [SD, 21]) and treatment duration (mean, 20 days [SD, 18] for studies giving growth hormone for >1 day) varied. Lean body mass increased in growth hormone recipients compared with participants who did not receive growth hormone (increase, 2.1 kg [95% CI, 1.3 to 2.9 kg]), but strength and exercise capacity did not seem to improve. Lactate levels during exercise were statistically significantly higher in 2 of 3 studies that evaluated this outcome. Growth hormone-treated participants more frequently experienced soft tissue edema and fatigue than did those not treated with growth hormone.
Few studies evaluated athletic performance. Growth hormone protocols in the studies may not reflect real-world doses and regimens.
Claims that growth hormone enhances physical performance are not supported by the scientific literature. Although the limited available evidence suggests that growth hormone increases lean body mass, it may not improve strength; in addition, it may worsen exercise capacity and increase adverse events. More research is needed to conclusively determine the effects of growth hormone on athletic performance.
据报道,人类生长激素被用于提高运动成绩,尽管其在此目的上的安全性和有效性尚不清楚。
评估生长激素对身体健康的年轻个体运动成绩影响的证据。
检索MEDLINE、EMBASE、SPORTDiscus和Cochrane协作网数据库,查找1966年1月至2007年10月发表的英文研究。
在13至45岁的社区居住健康参与者中,比较生长激素治疗与无生长激素治疗的随机对照试验。
两名作者独立审查文章并提取数据。
44篇描述27个研究样本的文章符合纳入标准;303名参与者接受了生长激素治疗,相当于13.3人年的治疗量。参与者较为年轻(平均年龄27岁[标准差3岁]),体型偏瘦(平均体重指数24kg/m²[标准差2]),身体健康(平均最大摄氧量51mL/(kg体重·分钟)[标准差8])。生长激素剂量(平均36μg/(kg·天)[标准差21])和治疗持续时间(给予生长激素超过1天的研究中平均20天[标准差18])各不相同。与未接受生长激素的参与者相比,接受生长激素的参与者瘦体重增加(增加2.1kg[95%置信区间,1.3至2.9kg]),但力量和运动能力似乎并未改善。在评估此结果的3项研究中的2项中,运动期间的乳酸水平在统计学上显著更高。接受生长激素治疗的参与者比未接受生长激素治疗的参与者更频繁地出现软组织水肿和疲劳。
很少有研究评估运动成绩。研究中的生长激素方案可能无法反映实际剂量和疗程。
科学文献不支持生长激素能提高身体机能的说法。尽管有限的现有证据表明生长激素可增加瘦体重,但可能无法增强力量;此外,它可能会降低运动能力并增加不良事件。需要更多研究来最终确定生长激素对运动成绩的影响。